FDA Adverse Event Injury Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4161929 · Received October 10, 2014

Report

Report Number
2032227-2014-36126
Event Type
Injury
Date Received
October 10, 2014
Date of Event
September 9, 2014
Report Date
September 11, 2014
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY, IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE, THEREFORE, CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE. THIS MDR RELATED TO THE (B)(4) MANUFACTURING SITE HAS BEEN ASSIGNED A MEDWATCH NUMBER FROM THE MEDTRONIC MINIMED (B)(4).

Description of Event or Problem · 1

CUSTOMER REPORTED SHE WAS HOSPITALIZED DUE TO A KINK IN HER INFUSION SET. DATE OF HOSPITALIZATION WAS (B)(6) 2014. BLOOD GLUCOSE AT THE TIME OF HOSPITALIZATION WAS 473 MG/DL. SHE STATED SHE WAS VOMITING SEVERELY AND WAS FEELING LOW ON ENERGY PRIOR TO HER HOSPITALIZATION. SHE ALSO REPORTED THE EMERGENCY MEDICAL SERVICES WAS CALLED AND THEY HAD TREATED HER WITH INSULIN. CUSTOMER ALSO STATED THE EMERGENCY RESPONDERS HAD TAKEN HER OFF THE INSULIN PUMP IN ORDER TO TREAT HER BLOOD GLUCOSE. THE CUSTOMER ALSO STATED SHE WAS HOSPITALIZED DUE TO HAVING DIABETES KETOACIDOSIS. THE CUSTOMER WAS TREATED WITH AN IV AND WAS SENT HOME WITH NOVOLOG AND LANTUS IN ADDITION TO SYRINGES. THE CUSTOMER STATED THIS WAS THE THIRD TIME SHE HAD THIS ISSUE. SHE ALSO REPORTED SHE WAS PREVIOUSLY HOSPITALIZED FOR DIABETES KETOACIDOSIS FOR THE SAME ISSUE WITH HER INFUSION SET. NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
644810 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-723NAH

Patients

Seq Age Sex Outcome Treatment
1 59 YR Hospitalization